NCT03951467

Brief Summary

Health literacy is the ability to access, understand, evaluate and apply information in order to communicate with health professionals and understand health instructions but also, promote, maintain and improve health throughout life. Health literacy is known as a health determinant. Level of Health Literacy is low or limited within 47% of interrogated people in Europe, resulting in an inability to understand and/or use written texts and digital concepts about one's health. There is a demonstrated link between low HL and low therapeutic adherence, an increase in the number of re-admissions, and more generally poor health or survival that is even more limited. An association between low LS and higher health care costs has also been reported in the USA and Switzerland. WHO highlight the central role of Health Literacyin health inequalities, regardless of the region of the world. The investigator chose to conduct this study in patients hospitalized for an acute cardiovascular event: acute myocardial infarction or acute decompensated heart failure , as these patients have cumulative risk factors for misuse and medication errors. They are hospitalized in emergency, for shorter and shorter periods and are discharged with complex drug treatments. The data show that the return home after acute hospitalization for these conditions is a particularly high-risk period for medication errors and misuse, especially with low level of Health Literacy. The proportion of patients with preventable adverse events in the weeks following their return home ranges from 23% to 30% and nearly 60% are re-hospitalized within 6 months. The hypothesis of the study is that in patients hospitalized for cute myocardial infarctionor acute decompensated heart failurewith low Health Literacy levels, information on discharge treatment using appropriate tools and techniques will reduce the risk of patient-related medication errors or misuse within 30 days of discharge. The purpose of this study is to develop an educational intervention model adapted to low Health Literacy levels and routinely feasible, even in case of short stays, in complementarity with traditional therapeutic education programmes that require higher investments and are therefore not accessible to all patients. This innovative approach could then be applied to a large number of chronic diseases.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
300

participants targeted

Target at P75+ for not_applicable

Timeline
19mo left

Started Jun 2025

Typical duration for not_applicable

Geographic Reach
1 country

4 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress35%
Jun 2025Dec 2027

First Submitted

Initial submission to the registry

May 14, 2019

Completed
1 day until next milestone

First Posted

Study publicly available on registry

May 15, 2019

Completed
6.1 years until next milestone

Study Start

First participant enrolled

June 26, 2025

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 26, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 26, 2027

Last Updated

July 14, 2025

Status Verified

July 1, 2025

Enrollment Period

2.5 years

First QC Date

May 14, 2019

Last Update Submit

July 9, 2025

Conditions

Keywords

LiteracyCardiovascular DiseasesInterventional studyRandomized Controlled TrialTertiary preventionHealth promotion

Outcome Measures

Primary Outcomes (1)

  • Patient-related medication errors or misuse within 30 days of discharge from hospital.

    This criterion is defined as the proportion of patients who have made a medication error or misuse, with or without a clinical consequence. We will focus on patient-related medication errors and misuse, i.e. non-compliance with prescription (shorter or longer treatment time, dosage changes, self-medication, etc.), based on the definition proposed by Kripalani et al. An adjudication committee composed of three independent experts will be responsible for defining the potential severity of drug errors or misuses related to the main judgement criterion. Data on primary endpoint will be collected by a clinical researcher, blinded to the randomization group, using a standardized questionnaire administered during the 30-day telephone interview. The patient will be asked the names of the treatments, how he/she took them (number of units per intake, frequency of intake,...), self-medication taken and medical follow-up (medical consultations, biological follow-up,...) over the past 30 days.

    Day 30

Study Arms (2)

Interventional arm

EXPERIMENTAL
Other: Interventional educational toolkit specific to low Health Literacy patients, designed with patients and health professionals.

Controlled arm

NO INTERVENTION

Patients within this arm will be follow as usual care of the cardiologic unit

Interventions

Three interviews between the patient and a health advisor trained for the study: two times before discharge from hospital and a telephone reminder within 3 weeks after discharge. First and second interview: the nurse will evolve using tools developed in the first phase of the study. The nurse will provide detailed personalized information on the patient's discharge order and illness and the action to be taken depending on the potential situations the patient may encounter. Telephone interview: within 3 weeks after discharge, the nurse will repeat the elements of the first interview with the patient to verify that the information has been properly understood and retained and that the patient is able to adopt appropriate behaviors in high-risk situations. Two interviews by phone with a clinical reseach assistant at 30 days et 90 days after discharge which consist of questionnaire.

Interventional arm

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age greater than or equal to 18 years
  • Hospitalization for at least a 2nd acute attack (systolic or diastolic)
  • Patient living at home before hospitalization for decompensation
  • Affiliated with a health insurance plan

You may not qualify if:

  • Short-term vital prognosis
  • Bipolar disorders, active psychoses
  • Severe dementia
  • Pregnant, parturient or breastfeeding women
  • Persons deprived of liberty by a judicial or administrative decision
  • Persons admitted to a health or social establishment for purposes other than research
  • Adults subject to a legal protection measure (guardianship, curatorship)
  • Score S-TOFHLA (\>22)
  • Withdrawal of consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

Hôpital Louis Pradel

Bron, 69500, France

RECRUITING

Public Health Department

Lyon, France

RECRUITING

Hôpital Lyon Sud

Pierre-Bénite, 69495, France

RECRUITING

SSR Val Rosay

Saint-Didier-au-Mont-d'Or, 69370, France

RECRUITING

MeSH Terms

Conditions

LiteracyCardiovascular Diseases

Interventions

Health Personnel

Condition Hierarchy (Ancestors)

CommunicationBehavior

Intervention Hierarchy (Ancestors)

Health Care Facilities Workforce and Services

Study Officials

  • Julie HAESEBAERT, MD

    Hospices Civils de Lyon

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 14, 2019

First Posted

May 15, 2019

Study Start

June 26, 2025

Primary Completion (Estimated)

December 26, 2027

Study Completion (Estimated)

December 26, 2027

Last Updated

July 14, 2025

Record last verified: 2025-07

Data Sharing

IPD Sharing
Will not share

Locations